MedPath

Flotrex

Flotrex (0.5 mg Fluoride) Prescribing Information

Approved
Approval ID

2e0e51f3-ee2c-540d-e063-6294a90a9275

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 3, 2025

Manufacturers
FDA

PureTek Corporation

DUNS: 785961046

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Multivitamins, Sodium Fluoride 0.5 mg

PRODUCT DETAILS

NDC Product Code59088-015
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationORAL
Effective DateMarch 3, 2025
Generic NameMultivitamins, Sodium Fluoride 0.5 mg

INGREDIENTS (20)

SUCROSEInactive
Code: C151H8M554
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
D&C RED NO. 27Inactive
Code: 2LRS185U6K
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
ASPARTAMEInactive
Code: Z0H242BBR1
Classification: IACT
SODIUM FLUORIDEActive
Quantity: 0.5 mg in 1 1
Code: 8ZYQ1474W7
Classification: ACTIM
ASCORBIC ACIDActive
Quantity: 24 mg in 1 1
Code: PQ6CK8PD0R
Classification: ACTIB
SODIUM ASCORBATEActive
Quantity: 36 mg in 1 1
Code: S033EH8359
Classification: ACTIM
CHOLECALCIFEROLActive
Quantity: 10 ug in 1 1
Code: 1C6V77QF41
Classification: ACTIB
THIAMINE MONONITRATEActive
Quantity: 1.05 mg in 1 1
Code: 8K0I04919X
Classification: ACTIR
RIBOFLAVINActive
Quantity: 1.2 mg in 1 1
Code: TLM2976OFR
Classification: ACTIB
NIACINAMIDEActive
Quantity: 13.5 mg in 1 1
Code: 25X51I8RD4
Classification: ACTIB
PYRIDOXINE HYDROCHLORIDEActive
Quantity: 1.05 mg in 1 1
Code: 68Y4CF58BV
Classification: ACTIM
FOLIC ACIDActive
Quantity: 300 ug in 1 1
Code: 935E97BOY8
Classification: ACTIB
CYANOCOBALAMINActive
Quantity: 4.5 ug in 1 1
Code: P6YC3EG204
Classification: ACTIB
VITAMIN AActive
Quantity: 750 ug in 1 1
Code: 81G40H8B0T
Classification: ACTIB
.ALPHA.-TOCOPHEROL ACETATE, DL-Active
Quantity: 6.75 mg in 1 1
Code: WR1WPI7EW8
Classification: ACTIM

Drug Labeling Information

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 5/19/2011

INDICATIONS AND USAGE

This prescription chewable tablet is indicated for the prevention and treatment of vitamin and fluoride deficiencies in patients at high risk for dental caries and inadequate dietary intake of essential vitamins. It is specifically formulated to support normal growth and development, promote bone and dental health, and aid in the maintenance of overall metabolic and immune function.

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 2/13/2025

Contraindications:

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

The American Academy of Pediatrics recommends that children up to the age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation.

Flotrex™ Chewable Multivitamin Tablets with 0.5 mg Fluoride provide 0.50 mg fluoride in tablet form for children 6-16 years of age in areas where the drinking water fluoride level is less than 0.3 ppm.

Flotrex™ Chewable Multivitamin Tablets with 0.5 mg Fluoride supply significant amounts of Vitamins A, C, D, E, thiamine, riboflavin, niacin, vitamin B6, vitamin B12, and folate to supplement the diet, and to help assure that nutritional deficiencies of these vitamins will not develop. Thus, in a single easy-to-use preparation, children obtain ten essential vitamins and the important mineral, fluoride.

Children using**Flotrex™ Chewable Multivitamin Tablets with 0.5 mg Fluoride **regularly should receive semiannual dental examinations. The regular brushing of teeth and attention to good oral hygiene practices are also essential.

Flotrex™ Chewable Multivitamin Tablets with 0.5 mg Fluoride is a prescription product for the clinical dietary management of the metabolic processes of caries prophylaxis and provides supplementation of the diet with ten essential vitamins.

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 5/19/2011

ADVERSE REACTIONS

Folate: Allergic sensitization has been reported following both oral and parenteral administration of folate. Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels.

CLINICAL PHARMACOLOGY SECTION

LOINC: 34090-1Updated: 2/13/2025

CLINICAL PHARMACOLOGY

It is well established that fluoridation of the water supply (1 ppm fluoride) during the period of tooth development leads to a significant decrease in the incidence of dental caries.

Flotrex™ Chewable Multivitamin Tablets with 0.5 mg Fluoride provide sodium fluoride and ten essential vitamins in a chewable tablet. Because the tablets are chewable, they provide a topical as well as systemic source of fluoride. Hydroxyapatite is the principal crystal for all calcified tissue in the human body. The fluoride ion reacts with the hydroxyapatite in the tooth as it is formed to produce the more caries-resistant crystal, fluorapatite. The reaction may be expressed by the equation:

Ca 10(PO 4) 6(OH) 2 + 2F - ------- Ca 10(PO 4) 6F 2 + 2OH -

(Hydroxyapatite) (Fluorapatite)

Three stages of fluoride deposition in tooth enamel can be distinguished:

1. Small amounts (reflecting the low levels of fluoride in tissue fluids) are incorporated into the enamel crystals while they are being formed.

2. After enamel has been laid down, fluoride deposition continues in the surface enamel. Diffusion of fluoride from the surface inward is apparently restricted.

3. After eruption, the surface enamel acquires fluoride from the water, food, supplementary fluoride and smaller amounts from saliva.

WARNINGS SECTION

LOINC: 34071-1Updated: 5/19/2011

WARNING

Keep out of the reach of children. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.

**Caution:**Do not eat or drink dairy products within one hour of fluoride administration.

Should be chewed. This product, as all chewable tablets, is not recommended for children under age 4 due to risk of choking.

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 5/19/2011

PRECAUTION

The suggested dose ofFlotrex™ Chewable Multivitamin Tablets with 0.5 mg Fluoride should not be exceeded, since dental fluorosis may result from continued ingestion of large amounts of fluoride. Before prescribing Flotrex™ Chewable Multivitamin Tablets with 0.5 mg Fluoride:

1. Determine the fluoride content of the drinking water from all major sources.

2. Make sure the child is not receiving significant amounts of fluoride from other sources such as medications and swallowed toothpaste.

3. Periodically check to make sure that the child does not develop significant dental fluorosis.

Folate in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.There is a potential danger in administering folate to patients with undiagnosed anemia, since folate may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia. The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 5/19/2011

DOSAGE AND ADMINISTRATION

One tablet daily, to be dissolved in the mouth or chewed before swallowing. Do not give a chewable tablet to a child younger than 4 years old.

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 2/13/2025

STORAGE

Do not use if bottle seal is broken.

Store at controlled room temperature 20° to 25°C (68° to 77°F).

[See USP Controlled Room Temperature].

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Flotrex - FDA Drug Approval Details